29.07.2009 11:00:00

Spectranetics to Present at Canaccord Adams’ 29th Annual Global Growth Conference on August 12

Spectranetics Corporation (Nasdaq: SPNC) today announced that it will present at Canaccord Adams’ 29th Annual Global Growth Conference to be held in Boston from August 11-13 at the Intercontinental Boston Hotel.

Emile J. Geisenheimer, Spectranetics’ chairman, president and chief executive officer, is scheduled to speak on Wednesday, August 12, 2009 at 11:00 a.m. Eastern time (9:00 a.m. Mountain time) and will discuss the Company's strategic initiatives, product pipeline and market opportunities.

Interested parties can access a live audio webcast and slide presentation at www.spectranetics.com. An archived presentation will be available on the Web site for 14 days.

The Canaccord Adams Global Growth Conference is one of the oldest and largest programs showcasing both publicly traded and privately held growth companies. Many of the presenting public companies are covered by Canaccord Adams’ global team of equity analysts. To learn more about the conference, please contact Nadine Miller at 617.371.3842 or Nadine.Miller@CanaccordAdams.com.

About Spectranetics

Spectranetics manufactures and markets the only Excimer Laser System approved in the United States, Canada, Europe and Japan for use in minimally invasive interventional procedures within the cardiovascular system. More than 800 Spectranetics laser systems are used in hospitals worldwide.

The Company’s Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries above and below the knee and within coronary arteries. The Company also markets aspiration catheters for the removal of thrombus and support catheters to facilitate crossing of coronary and peripheral arterial blockages.

The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of pacemaker and defibrillator cardiac leads.

For more information, visit www.spectranetics.com

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Spectranetics Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Spectranetics Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 926,72 0,12%